These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 8249599)
21. Synthesis of podophyllotoxin congeners as potential DNA topoisomerase II inhibitors. Kamal A; Atchison K; Daneshtalab M; Micetich RG Anticancer Drug Des; 1995 Oct; 10(7):545-54. PubMed ID: 7495478 [TBL] [Abstract][Full Text] [Related]
22. Hemi-synthesis and biological activity of new analogues of podophyllotoxin. Roulland E; Magiatis P; Arimondo P; Bertounesque E; Monneret C Bioorg Med Chem; 2002 Nov; 10(11):3463-71. PubMed ID: 12213460 [TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and biological evaluation of novel spin-labeled derivatives of podophyllotoxin as potential antineoplastic agents. Part XII. Yang L; Liu YQ; Tan H; Li WG; Tian X Nat Prod Res; 2007 Sep; 21(11):998-1008. PubMed ID: 17691049 [TBL] [Abstract][Full Text] [Related]
24. Antitumor agents. Part 232: Synthesis of cyclosulfite podophyllotoxin analogues as novel prototype antitumor agents. Xiao Z; Han S; Bastow KF; Lee KH Bioorg Med Chem Lett; 2004 Mar; 14(6):1581-4. PubMed ID: 15006408 [TBL] [Abstract][Full Text] [Related]
25. Antitumor agents. 234. Design, synthesis, and biological evaluation of novel 4beta-[(4' '-benzamido)-amino]-4'-o-demethyl-epipodophyllotoxin derivatives. Xiao Z; Bastow KF; Vance JR; Sidwell RS; Wang HK; Chen MS; Shi Q; Lee KH J Med Chem; 2004 Oct; 47(21):5140-8. PubMed ID: 15456257 [TBL] [Abstract][Full Text] [Related]
26. Synthesis of 4beta-amido and 4beta-sulphonamido analogues of podophyllotoxin as potential antitumour agents. Kamal A; Ashwini Kumar B; Arifuddin M; Dastidar SG Bioorg Med Chem; 2003 Nov; 11(23):5135-42. PubMed ID: 14604676 [TBL] [Abstract][Full Text] [Related]
27. Studies on lignan lactone antitumor agents. I. Synthesis of aminoglycosidic lignan variants related to podophyllotoxin. Saito H; Yoshikawa H; Nishimura Y; Kondo S; Takeuchi T; Umezawa H Chem Pharm Bull (Tokyo); 1986 Sep; 34(9):3733-40. PubMed ID: 3815595 [No Abstract] [Full Text] [Related]
28. [A multivariate analysis approach to antineoplastic and antiviral structure-activity relationships to a series of podophyllotoxins]. Doré JC; Viel C; Pageot N; Gordaliza M; Castro A; del Corral JM; Feliciano AS J Pharm Belg; 1996; 51(1):9-18. PubMed ID: 8882445 [TBL] [Abstract][Full Text] [Related]
29. Requirements for P-glycoprotein recognition based on structure-activity relationships in the podophyllotoxin series. Etievant C; Schambel P; Guminski Y; Barret JM; Imbert T; Hill BT Anticancer Drug Des; 1998 Jun; 13(4):317-36. PubMed ID: 9627671 [TBL] [Abstract][Full Text] [Related]
30. Effects of spin labeled derivatives of podophyllotoxin on cell cycle and macromolecular synthesis in human lymphoid leukemia Molt 4B cells. Wang JZ; Tsumura H; Shimura K; Tian X; Ito H Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):501-5. PubMed ID: 10437132 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological study of a new series of 4'-demethylepipodophyllotoxin derivatives. Duca M; Guianvarc'h D; Meresse P; Bertounesque E; Dauzonne D; Kraus-Berthier L; Thirot S; Léonce S; Pierré A; Pfeiffer B; Renard P; Arimondo PB; Monneret C J Med Chem; 2005 Jan; 48(2):593-603. PubMed ID: 15658872 [TBL] [Abstract][Full Text] [Related]
32. Studies on lignan lactone antitumor agents. II. Synthesis of N-alkylamino- and 2,6-dideoxy-2-aminoglycoside lignan variants related to podophyllotoxin. Saito H; Yoshikawa H; Nishimura Y; Kondo S; Takeuchi T; Umezawa H Chem Pharm Bull (Tokyo); 1986 Sep; 34(9):3741-6. PubMed ID: 3815596 [No Abstract] [Full Text] [Related]
33. Synthesis and biological evaluation of novel conjugates of podophyllotoxin and 5-FU as antineoplastic agents. Chen SW; Xiang R; Liu J; Tian X Bioorg Med Chem; 2009 Apr; 17(8):3111-7. PubMed ID: 19324555 [TBL] [Abstract][Full Text] [Related]
34. Bioactive constituents from roots of Bursera tonkinensis. Jutiviboonsuk A; Zhang H; Tan GT; Ma C; Van Hung N; Manh Cuong N; Bunyapraphatsara N; Soejarto DD; Fong HH Phytochemistry; 2005 Dec; 66(23):2745-51. PubMed ID: 16289147 [TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and cytotoxicity of novel podophyllotoxin derivatives. Yu PF; Chen H; Wang J; He CX; Cao B; Li M; Yang N; Lei ZY; Cheng MS Chem Pharm Bull (Tokyo); 2008 Jun; 56(6):831-4. PubMed ID: 18520089 [TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents. Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838 [TBL] [Abstract][Full Text] [Related]
37. Antitumor agents. Part 227: Studies on novel 4'-O-demethyl-epipodophyllotoxins as antitumor agents targeting topoisomerase II. Xiao Z; Bastow KF; Vance JR; Lee KH Bioorg Med Chem; 2004 Jun; 12(12):3339-44. PubMed ID: 15158802 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of new spin-labeled derivatives of podophyllotoxin. Jin Y; Chen SW; Tian X Bioorg Med Chem; 2006 May; 14(9):3062-8. PubMed ID: 16406792 [TBL] [Abstract][Full Text] [Related]
39. Antitumor agents. 100. Inhibition of human DNA topoisomerase II by cytotoxic ether and ester derivatives of podophyllotoxin and alpha-peltatin. Thurston LS; Imakura Y; Haruna M; Li DH; Liu ZC; Liu SY; Cheng YC; Lee KH J Med Chem; 1989 Mar; 32(3):604-8. PubMed ID: 2537424 [TBL] [Abstract][Full Text] [Related]
40. Methyl ethers of podophyllotoxin-related cyclolignans. Miguel del Corral JM; Gordaliza M; Castro MA; Morales LJ; Lopez JL; San Feliciano A J Nat Prod; 1995 Jun; 58(6):870-7. PubMed ID: 7673931 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]